Abbott Laboratories has seen its consensus analyst price target notch a slight increase, moving from $144.40 to $144.47, as ...

What Happened? Shares of healthcare product and device company Abbott Laboratories (NYSE:ABT) fell 3.5% in the afternoon session after the company reported third-quarter financial results that met, ...

The court said D.B.'s parents could not meet the threshold for a product liability claim under Louisiana's Products Liability ...

Abbott Laboratories said on Friday it would release limited quantities of nutrition products that had been put on hold following a recall of some powdered infant formulas from its Michigan facility.

Abbott Laboratories has won a legal case claiming its Similac infant formula caused the death of a baby from necrotizing ...

Abbott Laboratories, the US-based baby-formula manufacturer, has released some products that were recalled following a salmonella scare. In a statement, the company said it is releasing limited ...

Abbott Laboratories has initiated a voluntary recall of certain lots of ready-to-feed liquid products for infants and children, including the brands Similac and Pedialyte Electrolyte Solution, due to ...

A federal judge handed Abbott Laboratories another win this week in its yearslong battle over the safety of its formulas for babies born prematurely — a decision that could have implications for ...

Healthcare product and device company Abbott Laboratories (NYSE:ABT) met Wall Street’s revenue expectations in Q3 CY2025, with sales up 6.9% year on year to $11.37 billion. Its non-GAAP profit of ...

"A small percentage of bottles (less than 1%) in the recalled lots have bottle caps that may hot have sealed completely," the company said in their announcement Friday Shafiq Najib is a former ...

The lawsuit claims these products, marketed as suitable for people with diabetes, contain harmful ingredients. The company also criticized the studies arguing they do not substantiate a link between ...